Trial Profile
Effects of micronized fenofibrate on fasting and postprandial lipoproteins, inflammatory mediators and thrombosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Fenofibrate (Primary)
- Indications Hypertriglyceridaemia; Metabolic syndrome
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 31 Jan 2007 New trial record.